These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats. Schaan BD; Irigoyen MC; Lacchini S; Moreira ED; Schmid H; Machado UF Auton Neurosci; 2005 Jan; 117(1):54-61. PubMed ID: 15620570 [TBL] [Abstract][Full Text] [Related]
6. Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats. da Silva AS; Dias LD; Borges JF; Markoski MM; de Souza MS; Irigoyen MC; Machado UF; Schaan BD Life Sci; 2013 Jul; 92(24-26):1174-9. PubMed ID: 23680377 [TBL] [Abstract][Full Text] [Related]
7. Renal denervation in an animal model of diabetes and hypertension: impact on the autonomic nervous system and nephropathy. Dias LD; Casali KR; Leguisamo NM; Azambuja F; Souza MS; Okamoto M; Machado UF; Irigoyen MC; Schaan BD Cardiovasc Diabetol; 2011 Apr; 10():33. PubMed ID: 21496329 [TBL] [Abstract][Full Text] [Related]
8. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats. D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls. Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592 [TBL] [Abstract][Full Text] [Related]
10. GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Leguisamo NM; Lehnen AM; Machado UF; Okamoto MM; Markoski MM; Pinto GH; Schaan BD Cardiovasc Diabetol; 2012 Aug; 11():100. PubMed ID: 22897936 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats. David-Silva A; Freitas HS; Okamoto MM; Sabino-Silva R; Schaan BD; Machado UF Life Sci; 2013 Nov; 93(22):805-13. PubMed ID: 24157454 [TBL] [Abstract][Full Text] [Related]
12. Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome. Huber M; Heiduschka P; Ziemssen F; Bolbrinker J; Kreutz R Hypertens Res; 2011 Jan; 34(1):103-12. PubMed ID: 20927114 [TBL] [Abstract][Full Text] [Related]
13. Insulin but not phlorizin treatment induces a transient increase in GLUT2 gene expression in the kidney of diabetic rats. Freitas HS; D'Agord Schaan B; da Silva RS; Okamoto MM; Oliveira-Souza M; Machado UF Nephron Physiol; 2007; 105(3):p42-51. PubMed ID: 17204838 [TBL] [Abstract][Full Text] [Related]
14. Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose. Sahin I; Aydin S Biotech Histochem; 2013 May; 88(3-4):153-60. PubMed ID: 23244237 [TBL] [Abstract][Full Text] [Related]
15. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146 [TBL] [Abstract][Full Text] [Related]
16. Experimental rat models to study the metabolic syndrome. Aleixandre de Artiñano A; Miguel Castro M Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025 [TBL] [Abstract][Full Text] [Related]
17. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study. Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome. Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058 [TBL] [Abstract][Full Text] [Related]
19. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Croze ML; Soulage CO Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390 [TBL] [Abstract][Full Text] [Related]
20. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes. D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]